Proteona

Proteona operates a precision medicine platform focused on immuno-oncology and immune profiling. Its innovative single-cell multi-omics technology utilizes DNA barcoded antibodies to deliver both proteomic and genomic insights from individual cells. This approach allows researchers to phenotype cells with standard protein markers while also gaining an in-depth understanding of cellular activity through gene expression analysis. By combining these two layers of information, Proteona aims to enhance clinical outcomes in cancer treatment and improve the overall understanding of immune responses in patients.